Phocas Financial Corp. Bristol Myers Squibb CO Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $131,207 - $155,368	1,916 New	1,916 $0
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $59,878 - $70,994	-1,400 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$44.62 - $49.34 $62,468 - $69,076	1,400 New	1,400 $0
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $63,168 - $75,320	-1,400 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$48.76 - $63.23 $68,264 - $88,522	1,400 New	1,400 $73,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.